Disentangling gender and racial myths from clinical descriptions of female prevalent symptoms

从女性普遍症状的临床描述中解开性别和种族神话

基本信息

  • 批准号:
    ES/Y007816/1
  • 负责人:
  • 金额:
    $ 16.17万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Fellowship
  • 财政年份:
    2023
  • 资助国家:
    英国
  • 起止时间:
    2023 至 无数据
  • 项目状态:
    未结题

项目摘要

My PhD research found that the myth of the hysterical female unintentionally influences the way in whichdoctors, researchers, and the public discuss, categorise, and treat female-prevalent symptoms.I compared expert (medical and academic) and patient accounts of PMS (Premenstrual Syndrome) with theavailable scientific data regarding cyclical symptoms. The main finding was that persistent gender mythsassociated with 'hysteria' were affecting participant descriptions. In particular, the untrue but surprisinglycommon belief that the healthy female body (first the womb, now the female sex hormones) causes seriousmental health issues was strongly reflected in the way in which PMS was described. Unfortunately, thisassumption wrongly positions 'all women' as biologically prone to irrational beliefs and behaviours (includingthe exaggeration, invention, or imagination of symptoms and other distressing experiences) (King, 2020).This gender myth appears to have contributed to the unscientific separation and prioritisation of typically mildpremenstrual mood changes, and the dismissal and de-prioritisation of far more common and severeexperiences of (cyclical) pain. Black and other racialised ethnicity patient participants appeared to be subject toeven higher levels of disbelief in their symptoms than White cisgender women, demonstrating how gender andrace myths may combine to worsen discriminatory beliefs and practices.Another major finding was that educational resources (from high school biology to specialist gynaecologytextbooks) reduce the menstrual cycle to just 'hormonal changes'. By omitting key information about thefemale reproductive system, a more likely cause of cyclical symptoms (inflammation) has been overlooked forthe past 100 years. This gap in education unintentionally reproduces the myth of the hormonal/ hystericalfemale and has led to 'bad science'- in that researchers have mistakenly assumed that the timing of symptomsmeans that they must be caused by hormonal changes (rather than the inflammation associated withovulation, thickening of the womb lining, and menstruation).Many clinical PMS studies have tried but failed to prove a causal relationship between the female sexhormones and cyclical symptoms. Tellingly, these consistently negative study findings were positioned by themedical PMS experts as evidence of the 'mysterious' nature of the female reproductive body rather thansuggestive of alternative scientific explanations. In fact, it appears that the pairing of 'women' and 'hormones'in medicine (and wider society) has severely limited the ability of researchers and clinicians to account forfemale-prevalent symptoms and conditions in any other terms.My PhD thesis concluded with a proposal for redefining problematic cyclical symptoms as PMI (PerimenstrualInflammation) to help steer societal and medical discourses away from persistent gender/ race myths andmetaphors towards more accurate explanations. It is hoped that this will help to account for, and attend to, theneeds of individual patients without accidentally stigmatising an entire gender and/ or racialised ethnicpopulation. I already have a contract with Bristol University Press to write a popular science book for academic and publicaudiences. I now need to publish my work in some influential medical and academic journals to gain greaterprofessional credibility. This will be needed if I am to secure further research funding and persuade thepublishers of school and medical textbooks to integrate more comprehensive information about the purposeand function of the healthy menstrual cycle. Ultimately, I hope to help boost patient and medical knowledge ofmenstrual health (and female-prevalent symptoms), improve treatment options and patient outcomes, andexpose the way in which societal myths have prevented this information from being taught before.
我的博士研究发现,歇斯底里女性的神话无意中影响了医生、研究人员和公众讨论、分类和治疗女性流行症状的方式。我将专家(医学和学术)和患者对PMS(经前综合征)的描述与有关周期性症状的现有科学数据进行了比较。主要的发现是,与“歇斯底里”相关的持续的性别神话影响了参与者的描述。特别是,健康的女性身体(首先是子宫,现在是女性性激素)会导致严重的精神健康问题,这种不真实但却非常普遍的信念强烈地反映在经前综合征的描述中。不幸的是,这种假设错误地将“所有女性”定位为在生理上倾向于非理性的信念和行为(包括夸大、虚构或想象症状和其他痛苦经历)(King,2020)。这种性别神话似乎导致了对典型的轻度经前情绪变化的不科学的分离和优先顺序,以及对更常见和更严重的(周期性)疼痛经历的忽视和去优先化。与白色顺性别女性相比,黑人和其他种族化的患者参与者似乎更不相信自己的症状,这表明性别和种族神话如何联合收割机可能会加剧歧视性信念和做法。另一个主要发现是教育资源(从高中生物到专业妇科教科书)将月经周期缩短为“荷尔蒙变化”。由于忽略了女性生殖系统的关键信息,在过去的100年里,一个更可能导致周期性症状(炎症)的原因被忽视了。这种教育上的差距无意中再现了荷尔蒙/歇斯底里女性的神话,并导致了“坏科学”-研究人员错误地认为,更年期的时间意味着它们必须由荷尔蒙变化引起(而不是与排卵相关的炎症,子宫内膜增厚,许多临床PMS研究试图证明女性性激素和周期性症状之间的因果关系,但未能成功。很能说明问题的是,这些一贯负面的研究结果被医学PMS专家定位为女性生殖体“神秘”本质的证据,而不是其他科学解释的暗示。事实上,看来医学上的“女性”和“荷尔蒙”的配对(以及更广泛的社会)严重限制了研究人员和临床医生用任何其他术语解释女性流行症状和状况的能力。我的博士论文以一项将有问题的周期性症状重新定义为PMI的提议结束。(围月经期炎症),以帮助引导社会和医学话语远离持久的性别/种族神话和隐喻,走向更准确的解释。希望这将有助于说明和照顾个别患者的需求,而不会意外地侮辱整个性别和/或种族化的种族人口。我已经和布里斯托大学出版社签了合同,要为学术界和公众写一本科普书。我现在需要在一些有影响力的医学和学术期刊上发表我的工作,以获得专业的可信度。如果我想获得进一步的研究资金,并说服学校和医学教科书的出版商整合关于健康月经周期的目的和功能的更全面的信息,这将是必要的。最终,我希望帮助提高患者和医学对月经健康(和女性流行症状)的认识,改善治疗选择和患者结果,并解释社会神话阻止这些信息被教授的方式。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sally King其他文献

Menstrual Leave: Good Intention, Poor Solution
A preliminary study of the effects of the number of consecutive days of training and days off on foal recall
  • DOI:
    10.1016/j.jveb.2021.05.012
  • 发表时间:
    2021-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jaymie Loy;Leigh Wills;Sally King;Kirsty Jenkins;Sarah Ellis;Hayley Randle
  • 通讯作者:
    Hayley Randle
The unwillingness of future U.S. physicians to limit adolescent prevention counseling to abstinence-only messages.
未来的美国医生不愿意将青少年预防咨询仅限于禁欲信息。
Beyond participation: making enterprise development really work for women
超越参与:让企业发展真正为女性服务
  • DOI:
    10.1080/13552074.2012.663638
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sally King;Hugo Sintes;M. Alemu
  • 通讯作者:
    M. Alemu
Early training of foals using the ISES training principles
  • DOI:
    10.1016/j.jveb.2018.11.001
  • 发表时间:
    2019-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Sally King;Leigh Wills;Hayley Randle
  • 通讯作者:
    Hayley Randle

Sally King的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

基于Gender的组织行为与管理理论研究
  • 批准号:
    70071027
  • 批准年份:
    2000
  • 资助金额:
    13.0 万元
  • 项目类别:
    面上项目

相似海外基金

Scientific Leadership Group Core
科学领导小组核心
  • 批准号:
    10595900
  • 财政年份:
    2023
  • 资助金额:
    $ 16.17万
  • 项目类别:
Northern California Acute Care Research Consortium (NORCARES)
北加州急症护理研究联盟 (NORCARES)
  • 批准号:
    10552463
  • 财政年份:
    2023
  • 资助金额:
    $ 16.17万
  • 项目类别:
Addressing Surgical Disparities at the Root; Working to improve diversity in the surgical workforce
从根本上解决手术差异;
  • 批准号:
    10639471
  • 财政年份:
    2023
  • 资助金额:
    $ 16.17万
  • 项目类别:
Addressing Disparities In Pain Management
解决疼痛管理方面的差异
  • 批准号:
    10642345
  • 财政年份:
    2023
  • 资助金额:
    $ 16.17万
  • 项目类别:
Society of Behavioral Medicine 2023 Annual Meeting & Scientific Sessions
行为医学学会2023年年会
  • 批准号:
    10681958
  • 财政年份:
    2023
  • 资助金额:
    $ 16.17万
  • 项目类别:
Maternal Fetal Medicine Units Network: University of California, San Francisco
母胎医学单位网络:加州大学旧金山分校
  • 批准号:
    10682872
  • 财政年份:
    2023
  • 资助金额:
    $ 16.17万
  • 项目类别:
Feasibility and acceptability of a father-based intervention to support adolescents reproductive health
以父亲为基础的干预措施支持青少年生殖健康的可行性和可接受性
  • 批准号:
    10666721
  • 财政年份:
    2023
  • 资助金额:
    $ 16.17万
  • 项目类别:
2/2 IMPRroving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)
2/2 血管疾病的改善结果 - 主动脉夹层 (IMPROVE-AD)
  • 批准号:
    10663555
  • 财政年份:
    2023
  • 资助金额:
    $ 16.17万
  • 项目类别:
Computational Strategies to Tailor Existing Interventions for First Major Depressive Episodes to Inform and Test Personalized Interventions
针对首次严重抑郁发作定制现有干预措施的计算策略,以告知和测试个性化干预措施
  • 批准号:
    10650695
  • 财政年份:
    2023
  • 资助金额:
    $ 16.17万
  • 项目类别:
Social Connectedness and Health among Gender Minority People of Color
性别少数有色人种的社会联系和健康
  • 批准号:
    10650066
  • 财政年份:
    2023
  • 资助金额:
    $ 16.17万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了